PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-4 (4)
 

Clipboard (0)
None

Select a Filter Below

Journals
Authors
more »
Year of Publication
1.  Correction: Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia 
PLoS ONE  2012;7(9):10.1371/annotation/74add513-eb1d-4fa1-ae2e-c3d2e7e735a0.
doi:10.1371/annotation/74add513-eb1d-4fa1-ae2e-c3d2e7e735a0
PMCID: PMC3463619
2.  Correction: Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia 
PLoS ONE  2012;7(3):10.1371/annotation/ea1a4c80-8dfd-496a-a273-d74c1fd6e069.
doi:10.1371/annotation/ea1a4c80-8dfd-496a-a273-d74c1fd6e069
PMCID: PMC3319575
3.  Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia 
PLoS ONE  2012;7(2):e31550.
TGFβ-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is considered a key intermediate in a multitude of innate immune signaling pathways. Yet, the specific role of TAK1 in the myeloid compartment during inflammatory challenges has not been revealed. To address this question, we generated myeloid-specific kinase-dead TAK1 mutant mice. TAK1 deficiency in macrophages results in impaired NF-κB and JNK activation upon stimulation with lipopolysaccharide (LPS). Moreover, TAK1-deficient macrophages and neutrophils show an enhanced inflammatory cytokine profile in response to LPS stimulation. Myeloid-specific TAK1 deficiency in mice leads to increased levels of circulating IL-1β, TNF and reduced IL-10 after LPS challenge and sensitizes them to LPS-induced endotoxemia. These results highlight an antiinflammatory role for myeloid TAK1, which is essential for balanced innate immune responses and host survival during endotoxemia.
doi:10.1371/journal.pone.0031550
PMCID: PMC3279403  PMID: 22348103

Results 1-4 (4)